体外膜氧合在严重肺挫伤创伤患者中的应用
该研究基于创伤质量改进项目数据库(2017—2020年)开展回顾性队列研究,纳入611例严重肺挫伤成人患者,其中106例(17%)接受ECMO。经1:1倾向性匹配后102对患者分析显示,ECMO组与常规管理组住院死亡率(37% vs 29%,p=0.23)、肺栓塞(5% vs 6%,p=0.76)、卒中(7% vs 3%,p=0.19)均无显著差异,但ECMO组呼吸机相关性肺炎发生率显著更低(14% vs 36%,p<0.001)。ECMO患者中63%存活出院,院内心脏骤停、严重颅脑损伤和年龄>50岁与较低生存率相关,抗凝药物使用与较高生存几率相关。作者结论认为ECMO在严重肺挫伤创伤患者中是安全的,可能与小并发症相关。
要点
- 严重肺挫伤患者接受ECMO与常规管理相比,住院死亡率无显著差异(37% vs 29%,p=0.23)。
- ECMO组呼吸机相关性肺炎发生率显著低于常规管理组(14% vs 36%,p<0.001)。
- ECMO患者中63%(67/106)存活出院;院内心脏骤停、严重颅脑损伤和年龄>50岁与较低生存率相关。
- 抗凝药物使用与ECMO患者较高生存几率相关。
- 作者认为无严重颅脑损伤、无心脏骤停且无抗凝禁忌的年轻患者可能从ECMO获益最大。
适用人群与场景
- 创伤质量改进项目数据库(2017—2020年)中诊断为严重肺挫伤的成人患者。
- 接受静脉-动脉或静脉-静脉ECMO,或因呼吸衰竭接受机械通气者。
研究设计与关键结果
- 研究类型为回顾性队列研究,使用创伤质量改进项目数据库(2017—2020年),共纳入611例严重肺挫伤患者,其中106例(17%)接受ECMO。
- 经1:1倾向性匹配后102对患者分析,ECMO组与常规管理组住院死亡率无显著差异(37% vs 29%,p=0.23)。
- ECMO组与常规管理组肺栓塞发生率无显著差异(5% vs 6%,p=0.76)。
- ECMO组与常规管理组卒中发生率无显著差异(7% vs 3%,p=0.19)。
- ECMO组呼吸机相关性肺炎发生率显著低于常规管理组(14% vs 36%,p<0.001)。
- 接受ECMO的患者中67例(63%)存活出院。
- 在接受ECMO的患者中,院内心脏骤停、严重颅脑损伤和年龄>50岁与较低生存率相关,抗凝药物使用与较高生存几率相关。
证据类型、等级与局限
- 证据类型为回顾性队列研究,证据等级为治疗/临床管理 Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ECMO在严重肺挫伤创伤患者中是安全的,可能与较低并发症相关。
- 作者认为无严重颅脑损伤、无心脏骤停且无抗凝禁忌的年轻患者可能从ECMO获益最大。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with pulmonary contusion (PC) may require extracorporeal membrane oxygenation (ECMO) due to respiratory failure refractory to conventional management. We aimed to compare outcomes in patients with major PC who received ECMO with those who received conventional management.
METHODS: We performed a retrospective cohort study using the Trauma Quality Improvement Program Database (2017-2020). We identified adult patients with major PC who underwent veno-arterial or veno-venous ECMO or had respiratory failure and received mechanical ventilation. The primary outcome was survival to discharge. Secondary outcomes included the rate of pulmonary embolism, stroke, and ventilator-associated pneumonia. We used 1:1 propensity matching to adjust for patient and injury characteristics. We used stepwise logistic regression to identify predictors of survival among PC patients undergoing ECMO.
RESULTS: We included 611 patients, of whom 106 (17%) underwent ECMO. Among 102 well-matched pairs, there was no difference in the rate of mortality (37% vs. 29%; p =0.23), pulmonary embolism (5% vs. 6%; p =0.76), or stroke (7% vs. 3%; p =0.19). The rate of ventilator-associated pneumonia was significantly lower in ECMO patients (14% vs. 36%; p <0.001). Among patients undergoing ECMO, 67 (63%) survived to discharge. In-hospital cardiac arrest, severe head injury, and age over 50 years were associated with lower survival, while anticoagulant use was associated with higher odds of survival.
CONCLUSION: ECMO is safe in trauma patients with major PC and may be associated with lower morbidity. Young patients without severe head injuries, cardiac arrest, and contraindications to anticoagulation may benefit most from ECMO. ( J Trauma Acute Care Surg. 2026;101: 573-579.).
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Rafaqat W, Simpson MK, Lagazzi E, et al. Extracorporeal membrane oxygenation in trauma patients with major pulmonary contusion. J Trauma Acute Care Surg. 2026. PMID: 42318910. doi:10.1097/TA.0000000000005026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。